Literature DB >> 30206345

Prevalence and safety of diazoxide in the neonatal intensive care unit.

Keyaria D Gray1, Kathryn Dudash2, Carla Escobar2, Colman Freel2, Tylah Harrison2, Chandler McMillan2, Mihai Puia-Dumitrescu1,2, C Michael Cotten1, Robert Benjamin1, Reese H Clark3, Daniel K Benjamin1,2, Rachel G Greenberg4,5.   

Abstract

OBJECTIVE: Diazoxide is used to treat infants with persistent hypoglycemia, but the prevalence of its use and adverse effects are not well described. We report demographic and clinical characteristics of infants treated with diazoxide in neonatal intensive care units (NICUs). STUDY
DESIGN: Retrospective cohort study of infants 24-41 weeks' gestation admitted to 392 NICUs from 1997-2016, comparing characteristics between hypoglycemic infants exposed/not exposed to diazoxide. For diazoxide courses > 1 day, we report percentages of infants starting diuretics and/or developing new ventilator/oxygen requirement during therapy.
RESULTS: Among 1,249,466 infants, 185,832 had hypoglycemia; 1066/185,832 (0.57%) received diazoxide. Diazoxide use increased over time (P = 0.001). Infants receiving diazoxide varied from 0-14.9% among centers. New diuretic courses were associated with 91/664 (14%), and new oxygen or ventilator requirement during therapy was associated with 64/556 (12%) and 34/647 (5%), respectively.
CONCLUSIONS: Diazoxide use in NICU settings has increased over time. Infants receiving diazoxide commonly received diuretics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30206345      PMCID: PMC6224295          DOI: 10.1038/s41372-018-0218-4

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   3.225


  30 in total

1.  Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.

Authors:  Fatma Demirel; Sevim Unal; I Ilker Çetin; Ihsan Esen; Aslihan Arasli
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

2.  Complications of diazoxide in the treatment of nesidioblastosis.

Authors:  D R Gillies
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

3.  Hyperinsulinaemic hypoglycaemia in small for dates babies.

Authors:  J E Collins; J V Leonard; D Teale; V Marks; D M Williams; C R Kennedy; M A Hall
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 4.  Postnatal glucose homeostasis in late-preterm and term infants.

Authors:  David H Adamkin
Journal:  Pediatrics       Date:  2011-02-28       Impact factor: 7.124

5.  The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism.

Authors:  Shuwen Hu; Zidi Xu; Jie Yan; Min Liu; Bing Sun; Wenjing Li; Yanmei Sang
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

6.  Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.

Authors:  S E Flanagan; R R Kapoor; G Mali; D Cody; N Murphy; B Schwahn; T Siahanidou; I Banerjee; T Akcay; O Rubio-Cabezas; J P H Shield; K Hussain; S Ellard
Journal:  Eur J Endocrinol       Date:  2010-02-17       Impact factor: 6.664

7.  New intrauterine growth curves based on United States data.

Authors:  Irene E Olsen; Sue A Groveman; M Louise Lawson; Reese H Clark; Babette S Zemel
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

Review 8.  The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.

Authors:  Klára Roženková; Maria Güemes; Pratik Shah; Khalid Hussain
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-06

9.  Impact of the Implementation of New WHO Diagnostic Criteria for Gestational Diabetes Mellitus on Prevalence and Perinatal Outcomes: A Population-Based Study.

Authors:  Katja Erjavec; Tamara Poljičanin; Ratko Matijević
Journal:  J Pregnancy       Date:  2016-12-21

Review 10.  Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Authors:  Alena Welters; Christian Lerch; Sebastian Kummer; Jan Marquard; Burak Salgin; Ertan Mayatepek; Thomas Meissner
Journal:  Orphanet J Rare Dis       Date:  2015-11-25       Impact factor: 4.123

View more
  4 in total

1.  Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide.

Authors:  Madeline L Keyes; Helen Healy; Katherine A Sparger; Lucas E Orth; Mayya Geha; Sergei Roumiantsev; Juan D Matute
Journal:  Pediatrics       Date:  2021-02       Impact factor: 7.124

2.  Atypical Causes of Severe Pulmonary Hypertension in Infancy.

Authors:  Myriam Almeida-Jones; Pooja Nawathe; Dor Markush; Ruchira Garg
Journal:  Glob Pediatr Health       Date:  2021-03-23

3.  Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.

Authors:  Xiaohong Chen; Lifang Feng; Hui Yao; Luhong Yang; Yuan Qin
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

4.  The danger of diazoxide in the neonatal intensive care unit.

Authors:  Jay Desai; Logan Key; Alyson Swindall; Kan Gaston; Ajay J Talati
Journal:  Ther Adv Drug Saf       Date:  2021-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.